Pricing Strategy for Device and Drug Combination
US-based biotech exploring how to obtain premium pricing for their medical device and drug, individually as well as their combination, for a treatment of eye diseases.
Client also sought to gain an understanding of the various ways for reimbursement of this combination procedure.
Understand means, conditions and feasibility for achieving premium pricing of the drug component.
Study published documents from public and private sectors to understand precedent/similar cases, rules/regulations and tendencies of the authorities. Includes stakeholder mapping.
Review pricing strategies from viewpoint of authorities to understand challenges in the absence of a formal process specific to a combinatorial product.
Provide multiple scenarios each with timelines and consequences
How best to approach the Japanese market.
The solutions e-Projection provided were based on evidence and exhaustive analysis of potential commercialization.
Based on strategic scenarios for reimbursement of this combination procedure, the client now understood the key to developing the technology in the Japanese market.
Key Project Capabilities
- Pricing and Market Access Consultation
- Regulatory Consultation
- Clinical Consultation
- Demand Analysis
- Market Research
- PowerPoint presentation
Informal interviews with government officials
Creative approaches to higher levels of value
Timelines and process maps
We help non-Japanese pharma/biotech companies
understand and expand into the Japanese market.